GLP-1 TV · Clinician
FDA Approves New Weight Loss Pill Foundayo—No Shots, Big Results?
Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
In this news segment, the host asks medical contributor the channel about a newly FDA-approved oral GLP-1 pill from Eli Lilly, which the host calls Foundayo. The speaker says it is still a GLP-1 drug and works the same way as the injections: it slows how fast food moves through the stomach so people feel full longer, and it acts on hunger centers in the brain to reduce cravings. He says the main difference is convenience. He contrasts it with the oral Wegovy pill approved a couple of months earlier, which he says must be taken on an empty stomach followed by a 30 minute fast. According to the speaker, this pill has no such restrictions and can be taken at any time, with food or water.
Published by Dr. Omer Awan on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
On effectiveness, the speaker explains that a pill generally takes about 30 to 45 minutes to reach the bloodstream, while a shot is absorbed more effectively. He cites studies in which people taking the drug for about 72 weeks lost about 12.4% of their body weight, which he puts at roughly 25 to 27 lbs. He says injections can produce losses of 15 to 20%, so the pill gives a somewhat smaller result, though he notes that even a 10% loss can lower the risk of high blood pressure, heart disease and stroke.
The speaker says obesity medications are meant for long-term use and that weight often returns when people stop. He lists common side effects as nausea, vomiting, constipation and diarrhea, and mentions rarer serious ones including kidney injury, pancreatitis and a type of thyroid cancer. He says people with a history of medullary thyroid cancer, gallbladder disease or pancreatitis should not take it, and that it is not intended for losing 5 or 10 pounds. He closes by saying a needle-free pill without restrictions could widen access, citing that 40% of US adults are obese.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:32 The speaker says the pill works like the injections, reducing hunger and cravings, but is easier to use.
- 1:03 He says the pill has no timing, food or water restrictions, unlike the oral Wegovy pill, which requires an empty stomach and a 30 minute fast.
- 2:05 He cites studies of about 72 weeks showing 12.4% body weight loss, roughly 25 to 27 lbs, versus up to 15 to 20% with injections.
- 3:05 The speaker says these drugs are meant for long-term use, with weight often regained after stopping, and lists common and rare side effects.
- 4:05 He names medullary thyroid cancer, gallbladder disease and pancreatitis as reasons not to take it, and says it is not for losing 5 or 10 pounds.
- 5:08 He says a needle-free pill without restrictions may increase access, citing 40% of US adults as obese.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Foundayo
Questions this video answers
How is the Foundayo pill different from Wegovy pills and GLP-1 shots?
The speaker says it works the same way as the injections but is a pill, so it is easier to use. He says it differs from the oral Wegovy pill because it has no restrictions: it can be taken any time of day, with food or water.
How much weight do people lose on the Foundayo pill?
The speaker cites studies in which people taking it for about 72 weeks lost about 12.4% of body weight, or roughly 25 to 27 lbs. He says injections can lead to losses of 15 to 20%.
Who should not take the Foundayo pill?
The speaker says people with a history of medullary thyroid cancer, gallbladder disease or pancreatitis should not take it. He also says it is not meant for someone wanting to lose only 5 or 10 pounds, and advises talking to a doctor first.
What are the side effects of the Foundayo pill?
The speaker says most people have minor side effects such as nausea, vomiting, constipation and diarrhea. He says a small number of patients have serious effects including kidney injury, pancreatitis and, very rarely, a type of thyroid cancer.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
FDA approves Wegovy pill, the first prescription pill for weight lossAccording to the video, the channel report, the FDA has approved the first prescription pill for weight loss that uses the same medicine as injectable GLP-1 drugs.- Already on a GLP-1? What your next month costs at every programToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
A New GLP-1 Weight Loss Pill Just Got Approved… Here’s Why Foundayo Is DifferentAccording to the video, the FDA has approved a new weight loss pill called Foundeo, also known as orforglipron, made by Eli Lilly.
Oral Wegovy vs Foundayo: Which GLP-1 Pill Is Better?The speaker, who describes herself as a triple-board certified endocrinologist and lifestyle medicine specialist, compares two oral GLP-1 medications: the Wegovy pill and a newer pill she refers to as Foundayo.
Foundayo Pill: Review & Dosing GuideAccording to the video, Foundayo (orforglipron) is a once-daily GLP-1 pill from Eli Lilly for adults with obesity, or overweight adults with at least one weight-related condition.
Everything you need to know about GLP-1 'skinny jabs' (and the new pill) | BBC NewsThis explainer answers common questions about GLP-1 weight loss medicines, sometimes called skinny jabs, including the first GLP-1 weight loss pill.
Can You Lose Weight With Just a Pill? A Doctor’s Review of FoundayoIn this video a doctor reviews Foundayo (orforglipron), a once-daily oral GLP-1 medication that she says the FDA approved on April 1, 2026.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- The best GLP-1 for weight loss, ranked by the evidence and then by the bill
By weight lost, the order is settled: tirzepatide (Zepbound) first at 20.2% in the only head-to-head, then semaglutide 7.2 mg (Wegovy HD) at 18.7%, then semaglutide 2.4 mg (Wegovy) at 13.7% to 15.6%, then the pills. By what you pay, the order nearly inverts: compounded semaglutide from $39 a month, the Wegovy tablet from $149, Wegovy pen $349, Zepbound $299 to $699 by dose. The best one is where those two lists meet for your budget and your plan.
- Every GLP-1 pill you can actually get, and what each one costs
Four swallowable GLP-1s exist now, and three of them launched in 2026. Rybelsus, the Wegovy pill and the Ozempic pill are all semaglutide in a tablet but are approved for different things; Foundayo is a different molecule entirely and the only one with no food or timing rules. Two are for weight, two are for type 2 diabetes, and the cheapest thing on most rankings is not any of them. Here is the whole landscape, with what each actually costs.
- What is GLP-1? The hormone, how the drugs work, and every GLP-1 medication on the market
GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It tells the pancreas to release insulin when blood sugar is high, holds back glucagon, slows how fast the stomach empties, and acts on the parts of the brain that regulate appetite. GLP-1 drugs copy that hormone but last far longer: a week for the injections, a day for the pills. Seven brands are on the US market, from Ozempic and Mounjaro for type 2 diabetes to Wegovy, Zepbound and Foundayo for weight loss.
Next steps
Foundayo prices
Find more like it
Side effectsWeigh-in and resultsFood noise and cravings
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.








